Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19047305

J. Clin. Oncol. 2009 Jan 10 27 2 193-8

Download in:

View as

General Info

PMID
19047305